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a  b  s  t  r  a  c  t
Countries  are  increasingly  publishing  health  system  performance  statistics  alongside  those
of their  peers,  to  identify  high  performers  and achieve  a continuously  improving  health
system.  The  aim  of  the  paper  is to  identify,  and  discuss  resolution  of, some  key  methodo-
logical  challenges,  which  arise  when  comparing  health  system  performance.  To  illustrate
the issues,  we  focus  on  two  OECD  ﬂagship  initiatives:  the  System  of  Health  Accounts  (SHA)  and
the Health  Care  Quality  Indicators  (HCQI)  project  and  refer  to two  main  actors:  a  coordinat-
ing agency,  which  proposes  and  collates  performance  data  and  second,  data  correspondents
in constituent  health  systems,  who  submit  data  to  the  coordinating  centre.  Discussion  is
structured  around  two  themes:  a set  of  must-do’s  (legitimacy  of the  coordinating  centre,
validity of  proposed  indicators,  feasibility  of data  collection  and technical  support  for  data
correspondents)  and  a set  of  trade-offs  (depth  vs. breadth  in the  number  of system  elements
compared,  aggregation  vs.  granularity  of  data,  ﬂexibility  vs.  consistency  of  indicator  deﬁni-
tions and inclusion  criteria).  Robust  fulﬁllment  of  the  must-do’s  and  transparent  resolution
of the trade-offs  both  depend  upon  effective  collaboration  between  the  coordinating  centre
and  data  correspondents,  and  a close  working  relationship  between  a technical  secretariat
rts.
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Countries are increasingly publishing health system
erformance statistics alongside those of their peers, to
dentify high performers, understand the drivers of suc-
ess and achieve a continuously improving health system
1,2]. Yet, while there has been a signiﬁcant expansion
n health systems’ interest and capacity for comparative
erformance measurement, efforts and output remain of
neven quality. Inappropriate focus on isolated indica-
ors, without a clear understanding of the methodological
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issues and inherent limitations underpinning them, or
of the wider historical and policy context within which
indicators should be interpreted, may  lead to serious mis-
conceptions and erroneous policy decisions. The aim of
the paper is to provide a high-level view of some of the
methodological challenges, which need to be addressed
when seeking to compare health system performance.
Although we hope the paper will support those designing
and implementing comparative performance programmes,
by crystallising some critical design questions and antic-
ipating key challenges, our principal aim is to support
end-users of comparative metrics to better understand
the limitations and strengths of the data they use. The
article focuses on the collection and publication of com-
parative data (the specialisms of the OECD) and less on
Open access under CC BY-NC-SA license.primary data generation or on how policy makers should
apply ﬁndings. We  do, however, consider issues around
the interpretation and contextualisation of performance
metrics.
r CC BY-NC-SA license.
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We  ground the discussion by concentrating on the
development of two OECD ﬂagship initiatives: the System of
Health Accounts (SHA) and the Health Care Quality Indicators
(HCQI) project. The former aims to provide a comparable
framework for the systematic description of ﬁnancial ﬂows
through a health system, showing where money comes
from, who manages it, and how it is used. Its objectives are
to promote transparency and accountability in all health
systems, from the simplest to the most complex [3]. SHA
data has been used to identify inefﬁciencies health sys-
tem performance and is recognized by the World Bank
as necessary underpinning information when seeking to
improve health system effectiveness and quality [4]. The
HCQI project complements this information on spending
with information on the value that health services create,
publishing a set of indicators which measure and compare
the quality of health service provision. At present, pub-
lished indicators include sets on chronic conditions (such
as hospital admission rates for asthma), on specialist care
(such as case-fatality rates after stroke or 5-year relative
survival after cancer) and on patient safety (such as post-
operative sepsis) [5].
Reference is made throughout to two main actors:
ﬁrst, a coordinating agency, which proposes, deﬁnes,
collates and publishes comparative data and second,
data correspondents in the constituent health systems of
interest, who submit data to the coordinating centre and
may  be national or regional health systems or individual
institutions. We  emphasize continuous and effective
dialogue between the coordinating agency and data corre-
spondents, as well as between a technical secretariat and
an advisory body of experts, as being central to resolution
of the challenges identiﬁed. To aid readers’ appreciation
of some of the methodological issues which arise when
comparing health system performance, further discussion
is structured around two themes: a set of must-do’s and a
set of trade-offs.
1. The must-do’s: legitimacy of the coordinating
centre
A necessary prerequisite is that the coordinating centre
has recognised legitimacy in its adoption of this role, vis à
vis data correspondents, advisory experts and end-users.
Such legitimacy potentially comprises several elements,
such as an established reputation in reporting health
system performance or freedom from ﬁnancial and other
conﬂicts of interest. In the case of the SHA, the ﬁrst signif-
icant development of measures of health expenditure at
individual country level occurred during the global eco-
nomic crisis of the 1970s, in parallel with advancements in
national economic accounts, when governments needed
a clearer picture of public and private spending on health.
Given the OECD’s long history as both convenor and secre-
tariat of intergovernmental conferences, technical support
for this agenda emerged naturally as part of OECD’s portfo-
lio. Efforts to harmonise national reporting standards into
a comparable international framework culminated in the
publication by OECD of A System of Health Accounts in 2000.
The endorsement of the SHA principles led to a revised
version of SHA being released in 2011 under the auspicesy 112 (2013) 4– 8 5
of OECD, WHO  and the European Commission, accepted
as the de facto global standard by the United Nations
Statistical Division (UNSD) [6]. Similarly, a high-level
intergovernmental conference in 2002 calling for health
systems to be governed not just on cost but also perfor-
mance, and for relevant actionable data, set the stage for
the HCQI project [7].
Another aspect underpinning on-going legitimacy is
that the coordinating centre is open and responsive to
feedback. For both SHA and HCQI, experts and data cor-
respondents are encouraged to suggest amendments and
improvements to the data collection, analysis and publi-
cation processes through six-monthly or annual technical
meetings. Likewise for end-users there is a constant ﬂow
of queries and replies via the database contact mechanism.
2. Validity of the performance indicators
There are many aspects of health system performance
potentially of interest (effectiveness, efﬁciency, equity,
safety etc.). To be measured and compared, each must link
to a valid metric. Most newly proposed metrics will at least
have ‘face’ validity (i.e. initially appear plausible) and ‘con-
tent’ validity (i.e. be accompanied by real-world studies
which support its plausbility). Other dimensions of valid-
ity, such as ‘construct’ (i.e. plausibly related indicator-sets
demonstrate expected covariance) or ‘criterion’ validity
(i.e. expected covariance with ultimate outcomes such
as health status), may  also be evident or may  emerge
with time. The extent to which other stakeholders accept
an indicator’s validity can be assessed through a variety
of techniques, such as the Delphi or RAND methods. In
essence, these techniques survey invited experts’ opin-
ions on the validity of the proposed indicator, individually
and/or collectively, via correspondence and/or in-person.
Suggested amendments can be incorporated and validity
re-tested through an iterative process. Detailed guidance,
on matters such as how many experts to survey, is available
[8].
Valid indicators need tight deﬁnition. All OECD com-
parative indicators are accompanied by detailed technical
manuals, which are the result of collective work between
a technical secretariat and a body of experts, continu-
ously reﬁned through use and application. A well-known
example is the SHA Manual [3]. This sets out in detail the
boundaries, deﬁnitions and concepts used to meet the need
for standardization and comparability of health spending
estimates over time and across countries. It is intended as
a reference and source of deﬁnitions and links to other sta-
tistical systems. It does not provide extensive guidance on
how to collect the data nor prescribe the level of detail of
data that should be collected, either at an international or
national level.
3. Feasibility of data collection
Once a valid metric has been agreed, feasibility of its
international collection must be assessed, that is, a clear
understanding of the practical constraints of collecting an
indicator. Some understanding may  be achieved by sur-
veying relevant experts in each constituency and explicitly
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sking their opinion on the feasibility of collection within
heir system. Reviewing the results typically implies a
eries of judgements, for example, how many constituents
eed to positively afﬁrm that robust reporting of the indi-
ator is feasible for an indicator to be worth pursuing?
ow much tolerance can be applied if experts report
eaknesses in the quality of the data available from their
ystem? If a proposed national indicator is not feasible,
ill a regional or institutional measure do as a proxy?
he trade-off is between publishing fully robust indica-
ors from few constituents, or a more populated indicator
et with acknowledged weaknesses. This latter option may
erve to stimulate interest, build capacity and set the stage
or wider reporting in the future. The mental healthcare
ndicators within the HCQI project illustrate the difﬁcul-
ies here. Historically, national suicide rates were typically
he only published indicator of mental healthcare quality,
 situation, which was widely viewed as unsatisfactory.
et review of around 200 additional candidate indicators
emonstrated that only two could be robustly reported
t national level, and even then by only a few countries:
eadmission rate after in-patient treatment for bipolar dis-
rder or schizophrenia. The decision was taken to restrict
ublication to these additional two, whilst working with
ountries to develop their technical competence in mea-
uring mental healthcare quality.
In the case of SHA, the Joint Health Accounts Ques-
ionnaire (JHAQ), based closely on SHA deﬁnitions and
dministered by the three coordinating agencies (OECD,
HO and Eurostat) has been a particularly successful
xample of continuously increasing the robustness of the
ata collection. Building on the feasibility testing of a
election of core expenditure and ﬁnancing variables from
onstituent countries, the annual collection has expanded
he coverage of data, both in terms of countries and detail,
ear on year since its inception in 2006.
A ﬁnal aspect of feasibility is the political acceptability
or otherwise) of publishing performance indicators, given
he risk of negative domestic and international commen-
ary if a country appears to be performing badly. Countries
lways retain the ﬁnal rights over publication of their data.
his should always be avoided however, since publica-
ion and making constituent data available (with additional
ommentary as necessary) to the wider community for
urther use, critique and research, strengthens the perfor-
ance comparison effort.
. Technical support for data correspondents
A third must-do concerns methodological support and
uality control at the coordinating centre, particularly giv-
ng data correspondents adequate support to report data
n a timely and robust manner. This can be achieved in
any ways, including carefully designed and user-friendly
ata submission platforms, technical manuals as men-
ioned earlier, workshops and effective coordination with
ther data collection efforts to avoid duplication or inefﬁ-
iently sequenced requests for data. The most important
actor is that support be structured and continuous. As
n example, SHA held a number of workshops and train-
ng sessions around the world, in conjunction with Worldy 112 (2013) 4– 8
Health Organisation, to help countries prepare for imple-
mentation of the new system of accounts. Regular meeting
of health accounts experts to review current data collection
submissions and experiences and discuss methodological
and technical advances has proved to be essential in this
respect. Likewise, showing data correspondents how their
data will be collated, analysed and published so that they
can see its relevance and potential policy use is extremely
useful.
Quality control at the coordinating centre also involves
close inspection of data, essentially to review plausibil-
ity. Some data errors may  be immediately evident, such as
proportions exceeding 100%, others may  be more implied,
such as a abrupt deviance from a previously steady trend.
Automated checks may  detect these or hand checking may
be required. In all cases, dialogue with the data corre-
spondent will be necessary to understand the nature of
any error and correct it. In the case of SHA, a full and
detailed validation procedure has been embedded in the
data collection process, and has been made increasingly
transparent to data correspondents to provide a system of
checks and balances to assist the initial compilation pro-
cess and reduce some of these initial errors. A process of
dialogue between the country and the coordinating agen-
cies is then pursued with the aim of a ﬁnal conﬁrmation of
the data to the satisfaction of all parties. Alongside these
speciﬁc instances of data assistance, the OECD maintains
an on-going programme to benchmark and support the
information technology capacity of countries health care
systems through the Benchmarking of Information and Com-
munication Technologies in Health Systems project and other
work streams [9].
5. The trade-offs: depth vs. breadth
One trade-off is whether to compare few or many sys-
tem elements, that is, between depth and breadth of the
performance comparison effort. When is it more useful
to offer international comparison of a few performance
elements in a robust and timely manner, or of several ele-
ments in a more ‘quick and dirty’ fashion? Health systems
are undeniably complex: with a broad array of objectives
(such as protecting and improving health and protecting
against ﬁnancial catastrophe), settings (whether commu-
nity or specialist settings, or virtual environments), inputs
(physical, ﬁnancial and workforce) and outcomes (includ-
ing health gain and positive patient experience). Giving a
meaningful snapshot of any healthcare activity, let alone
any higher organising concept such as ‘quality’ or ‘fair-
ness’, is unlikely to be easily reducible to a one or a few
comparable indicators, especially if an indicator’s construct
and criterion validity as referred to earlier remain unclear.
Whilst a diverse set of indicators may  in theory be nec-
essary to yield a sufﬁciently nuanced and representative
picture of healthcare performance, collection may  not be
feasible. Additionally, end-users may  have a preference for
fewer indicators, over a forest of data they have difﬁculty
synthesising into a single picture.
The trade-off between few and many data points is
often resolved by feasibility constraints; and in practice
fewer performance elements are collected from fewer
lth PolicI. Forde et al. / Hea
constituents than one would typically like. This is currently
the case with the HCQI project, which, although develop-
ing year on year, is nevertheless known to reﬂect a patchy
and incomplete picture of healthcare quality. The oppo-
site concern applies to the SHA database, which currently
contains a potential 90 million data points and continues
to grow with each annual data collection. Recent discus-
sion has therefore focussed on the value, or otherwise,
of such a highly detailed, granular database. One ques-
tion concerns whether all the available detail is actually
of interest: local government spending on hearing aids is
cited as an example of data which is collected, but which
may  never be relevant in policy discussions at international
level. Another concerns the resources which can be devoted
to validation and comparability veriﬁcation, both within
the coordinating and submitting organisation, as well as
the question of timeliness, since it can take some countries
a number of years before they can report data in the detail
requested.
As a database expands, other possible resolutions come
into play. One is that the coordinating centre publishes eas-
ily digestible performance summaries alongside the full
data set, the model seen in the OECD’s biannual Health
at a Glance publication [10]. Alternatively, the case may
be made to reorganise efforts to collect fewer data, whilst
putting more effort into ensuring comparability of what is
collected and focussing resources on performance compar-
ison in areas of high policy impact, which is the direction
in which the SHA is likely to move.
6. Aggregation vs. granularity
A related trade-off is that between aggregation and
granularity. Metrics of health system performance concep-
tually aggregated to a higher organising level (as single
measure of ‘fairness’ for example) or numerically aggre-
gated across a series of activities or institutions have the
appeal of being a quickly readable dashboard of diag-
nostics. This may, however, mask important contextual
detail and lead to erroneous conclusions if taken at face
value, without a deeper understanding of how composite
scores were derived or of any vagaries of the under-
lying data. On the other hand, the more granular data
become, the more likely they may  be determined by
country-speciﬁc or service-speciﬁc characteristics, losing
comparability (alongside the risk of data-overload). In gen-
eral, extreme caution is needed around any attempt to
publish aggregate performance indicators, for at least three
reasons. First, as noted above, indicators may  be too sparse
or patchy to reliably generate composites. Second, a series
of assumptions are necessary in the construction of any
composite indicator, around relative weighting of individ-
ual elements for example, inviting inevitable criticism and
disagreement. Third, statistical uncertainty renders any
ranking of performance as potentially misleading, unless
conﬁdence intervals are made clear. The controversy [11]
surrounding the World Health Organisation’s ranking of
health system performance in 2000 [12] illustrates these
issues.
The OECD, with the exception of recent exploratory
work around well-being and its Better Life Index [13], doesy 112 (2013) 4– 8 7
not attempt to derive composite indicators or rankings
and a more recent World Health Organisation report on
health system performance reports that, given the techni-
cal capabilities available at present, “usefulness of ‘whole
system’ performance comparison is open to question. . .
and may distract policy makers from identifying and
remedying the parts of their system that require attention”
[14]. A vitally important resolution both to this trade-
off and to the former is that comparative performance
indicators, whether few or many, aggregate or granular,
are not published in isolation but are accompanied by
careful commentary to allow users to understand their
limitations, relationship to other metrics and likely pol-
icy relevance. A core issue that such commentary must
address is bias. There is often uncertainty over the extent
to which indicators reﬂect healthcare activity as opposed
to healthcare recording activity: is an unusually low rate
of post-operative sepsis a cause for concern or for com-
mendation, for example? Related to the issue of bias is
that of confounding and, as a minimum, commentary must
explain how and whether adjustments were made for
age, sex or other socioeconomic differences. The two-page
format of Health at a Glance dedicates one page to such com-
mentary [10]. Recent work by the HCQI project is going
further and supplementing indicator sets with in-depth
policy surveys to try and explain in narrative terms why
some countries are performing better than others, along-
side extensive quantitative analytic work. The ﬁrst of these
will consider cancer care [15].
7. Flexibility vs. consistency
Finally, a trade-off exists between ﬂexibility and
consistency. Consistency of deﬁnitions, numerators and
denominators over time and across countries is self-
evidently important for comparisons to be valid and
historical trends to be reliably identiﬁed. Yet measurement
must also be ﬂexible enough to accommodate individual
countries’ interests and technical capacity, and changing
needs over time. Flexibility is probably made easier with
disaggregated data. The recently revised SHA Manual aims
to be consistent yet ﬂexible, applicable to any health system
in the world, from the simplest to the most complex. More
materials have been added to cover the needs of health
systems with very different organization and ﬁnancing
arrangements, including countries with complex health
systems requiring ﬁner and more detailed deﬁnitions and
classiﬁcations. It also aims to be “sufﬁciently ﬂexible to
accommodate future changes”, for example, as new meth-
ods of raising revenues and ﬁnancing health care evolve, or
the delivery of services or type of services change over time.
There are no clear resolutions to the trade-offs implied
here; instead, issues are best resolved by an on-going dia-
logue between a technical secretariat and representative
body of experts. At the OECD, this is formally structured by a
rolling-programme of six monthly meetings, underpinned
by a smaller and more ﬂexible panel of experts available
for ad-hoc consultation, and overseen by a Health Com-
mittee, which ensures that work of both the SHA and HCQI
programmes remains aligned to the broader programme of
work.
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. Conclusion
International comparison of health system performance
ust robustly fulﬁll a set of must-dos around legitimacy,
alidity, feasibility and technical support. Equally obliga-
ory, however, is the transparent resolution of a set of trade-
ffs around how many system elements are compared, at
hat level and how rigidly deﬁned. Emerging clearly as
ritical to successful resolution of both sets of challenges is
he need for key relationships to work effectively: ﬁrst, that
etween the coordinating centre and data correspondents,
o offer continuous technical support and quality control;
econd, that between a technical secretariat and a body of
xperts, to advise on indicator validity, feasibility and on
n-going trade-offs around breadth, detail and ﬂexibility.
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